Liver health Emerging evidence suggests that GLP-1s may have beneficial effects on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), conditions often associated with obesity and type 2 diabetes and more common in people with hypothyroidism
However, people taking these medicines must be watched closely because of uncommon, but serious adverse reactions: Infections from bacteria, viruses, and fungi Skin cancer, but not melanoma Skin reactions Allergic reactions Worsened heart failure Damage to nerves Low white blood cell count SURGERY Surgery may be needed to correct severely damaged joints
But your vial is 2.5mg/mL, not 5mg/mL
Bottom Line Ultimately, experiencing some side effects is a normal part of starting GLP-1 therapy for weight management
Per the Centers for Disease Control and Prevention's (CDC) 2023 data, obesity was only about 9% more common among women than among men in all age groups
Plant Physiol Jun
.png)
